Helena Katrina Tayton-martin - Net Worth and Insider Trading
Helena Katrina Tayton-martin Net Worth
The estimated net worth of Helena Katrina Tayton-martin is at least $0 dollars as of 2024-05-28. Helena Katrina Tayton-martin is the Chief Business Officer of Adaptimmune Therapeutics PLC and owns about 0 shares of Adaptimmune Therapeutics PLC (ADAP) stock worth over $0. Details can be seen in Helena Katrina Tayton-martin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Helena Katrina Tayton-martin has not made any transactions after 2020-08-03 and currently still holds the listed stock(s).
Transaction Summary of Helena Katrina Tayton-martin
Helena Katrina Tayton-martin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Helena Katrina Tayton-martin owns 1 companies in total, including Adaptimmune Therapeutics PLC (ADAP) .
Click here to see the complete history of Helena Katrina Tayton-martin’s form 4 insider trades.
Insider Ownership Summary of Helena Katrina Tayton-martin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | 2020-08-03 | Chief Operating Officer |
Helena Katrina Tayton-martin Latest Holdings Summary
Helena Katrina Tayton-martin currently owns a total of 1 stock. Helena Katrina Tayton-martin owns 0 shares of Adaptimmune Therapeutics PLC (ADAP) as of August 3, 2020, with a value of $0.
Latest Holdings of Helena Katrina Tayton-martin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | 2020-08-03 | 0 | 1.05 | 0 |
Holding Weightings of Helena Katrina Tayton-martin
Helena Katrina Tayton-martin Form 4 Trading Tracker
According to the SEC Form 4 filings, Helena Katrina Tayton-martin has made a total of 2 transactions in Adaptimmune Therapeutics PLC (ADAP) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Adaptimmune Therapeutics PLC is the sale of 200,000 shares on August 3, 2020, which brought Helena Katrina Tayton-martin around $2 Million.
Insider Trading History of Helena Katrina Tayton-martin
- 1
Helena Katrina Tayton-martin Trading Performance
Helena Katrina Tayton-martin Ownership Network
Helena Katrina Tayton-martin Owned Company Details
What does Adaptimmune Therapeutics PLC do?
Who are the key executives at Adaptimmune Therapeutics PLC?
Helena Katrina Tayton-martin is the Chief Operating Officer of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Medical Officer Elliot Norry , Chief Operating Officer Bertrand William C Jr , and Chief Patient Supply Officer John Lunger .
Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary
Over the past 18 months, Helena Katrina Tayton-martin made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 115,184 shares made by Adrian Rawcliffe , a net sale of 48,376 shares made by John Lunger , and a net sale of 46,074 shares made by Bertrand William C Jr .
In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 315,048 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,048 shares.
Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptimmune Therapeutics PLC Insider Transactions
Helena Katrina Tayton-martin Mailing Address
Above is the net worth, insider trading, and ownership report for Helena Katrina Tayton-martin. You might contact Helena Katrina Tayton-martin via mailing address: C/o Adaptimmune Therapeutics Plc, 60 Jubilee Ave, Milton Park, Abingdon, Oxfordshire X0 Ox14 4rx.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
